CD8A and cancer: In particular, drug repurposing and/or repositioning is a method for developing new treatments for cancers.42 In this study, we revealed a previously unappreciated role of the antiparasitic agent ABZ: it can induce an antitumor immune response by increasing CD8+ T cell cytotoxicity.